Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Thach Giao Truong"'
Autor:
Sapna P. Patel, Megan Othus, Yuanbin Chen, G. Paul Wright, Kathleen J. Yost, John R. Hyngstrom, Siwen Hu-Lieskovan, Christopher D. Lao, Leslie A. Fecher, Thach-Giao Truong, Jennifer L. Eisenstein, Sunandana Chandra, Jeffrey A. Sosman, Kari L. Kendra, Richard C. Wu, Craig E. Devoe, Gary B. Deutsch, Aparna Hegde, Maya Khalil, Ankit Mangla, Amy M. Reese, Merrick I. Ross, Andrew S. Poklepovic, Giao Q. Phan, Adedayo A. Onitilo, Demet G. Yasar, Benjamin C. Powers, Gary C. Doolittle, Gino K. In, Niels Kokot, Geoffrey T. Gibney, Michael B. Atkins, Montaser Shaheen, James A. Warneke, Alexandra Ikeguchi, Jose E. Najera, Bartosz Chmielowski, Joseph G. Crompton, Justin D. Floyd, Eddy Hsueh, Kim A. Margolin, Warren A. Chow, Kenneth F. Grossmann, Eliana Dietrich, Victor G. Prieto, Michael C. Lowe, Elizabeth I. Buchbinder, John M. Kirkwood, Larissa Korde, James Moon, Elad Sharon, Vernon K. Sondak, Antoni Ribas
Publikováno v:
New England Journal of Medicine. 388:813-823
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::572c5454e442063325a108f2b1da3b9a
https://doi.org/10.1056/nejmoa2211437
https://doi.org/10.1056/nejmoa2211437
Autor:
Joseph M. Unger, Amy Darke, Megan Othus, Thach-Giao Truong, Nikhil Khushalani, Kari Kendra, Karl D. Lewis, Bryan Faller, Pauline Funchain, Elizabeth I. Buchbinder, Ahmad A. Tarhini, John M. Kirkwood, Elad Sharon, Vernon Sondak, Samantha R. Guild, Kenneth Grossmann, Antoni Ribas, Sapna P. Patel
Publikováno v:
JAMA oncology.
ImportanceA key issue for the adjuvant treatment of patients with melanoma is the assessment of the effect of treatment on relapse, survival, and quality of life (QOL).ObjectiveTo compare QOL in patients with resected melanoma at high risk for relaps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6789b49f5388ef55c6ce495ba4a024d4
https://pubmed.ncbi.nlm.nih.gov/36416836
https://pubmed.ncbi.nlm.nih.gov/36416836
Autor:
Michael B. Atkins, Sandra J. Lee, Bartosz Chmielowski, Ahmad A. Tarhini, Gary I. Cohen, Thach-Giao Truong, Helen H. Moon, Diwakar Davar, Mark O'Rourke, Joseph J. Stephenson, Brendan D. Curti, Walter J. Urba, Joanna M. Brell, Pauline Funchain, Kari L. Kendra, Alexandra P. Ikeguchi, Anthony Jaslowski, Charles L. Bane, Mark A. Taylor, Madhuri Bajaj, Robert M. Conry, Robert J. Ellis, Theodore F. Logan, Noel Laudi, Jeffrey A. Sosman, David G. Crockett, Andrew L. Pecora, Ian J. Okazaki, Sowjanya Reganti, Sunandana Chandra, Samantha Guild, Helen X. Chen, Howard Z. Streicher, Jedd D. Wolchok, Antoni Ribas, John M. Kirkwood
Publikováno v:
Journal of Clinical Oncology. 41:186-197
PURPOSE Combination programmed cell death protein 1/cytotoxic T-cell lymphocyte-4–blockade and dual BRAF/MEK inhibition have each shown significant clinical benefit in patients with BRAFV600-mutant metastatic melanoma, leading to broad regulatory a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5b1385a7ab421246b7bc70886ef74c7
https://doi.org/10.1200/jco.22.01763
https://doi.org/10.1200/jco.22.01763
Autor:
Antoni Ribas, John M. Kirkwood, Larissa A. Korde, Elad Sharon, Nageatte Ibrahim, Sama Ahsan, Scot W. Ebbinghaus, Krishna S. Gunturu, Magdalena Kovacsovics-Bankowski, Brian Gastman, Zeynep Eroglu, James Moon, Hongli Li, Douglas B. Johnson, Ragini R. Kudchadkar, Bartosz Chmielowski, Robert M. Conry, Karl D. Lewis, Pauline Funchain, Kari Kendra, Elizabeth I. Buchbinder, Justine V. Cohen, Nikhil I. Khushalani, Thach-Giao Truong, Teresa M. Petrella, Michael V. Knopp, Vernon K. Sondak, Ahmad A. Tarhini, Sapna P. Patel, Megan Othus, Kenneth F. Grossmann
Supplementary Data from Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70860ad8a591df39f1504fb8bc1ae75a
https://doi.org/10.1158/2159-8290.22541236.v1
https://doi.org/10.1158/2159-8290.22541236.v1
Autor:
Juraj Kavecansky, Richie Xu, Lue-Yen Tucker, Jahan Tavakoli, Alexander Menter, Thach-Giao Truong
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bc6e836868cceef94f93e9757057e36
https://doi.org/10.1136/jitc-2022-sitc2022.0937
https://doi.org/10.1136/jitc-2022-sitc2022.0937
Autor:
Michael B, Atkins, Sandra J, Lee, Bartosz, Chmielowski, Ahmad A, Tarhini, Gary I, Cohen, Thach-Giao, Truong, Helen H, Moon, Diwakar, Davar, Mark, O'Rourke, Joseph J, Stephenson, Brendan D, Curti, Walter J, Urba, Joanna M, Brell, Pauline, Funchain, Kari L, Kendra, Alexandra P, Ikeguchi, Anthony, Jaslowski, Charles L, Bane, Mark A, Taylor, Madhuri, Bajaj, Robert M, Conry, Robert J, Ellis, Theodore F, Logan, Noel, Laudi, Jeffrey A, Sosman, David G, Crockett, Andrew L, Pecora, Ian J, Okazaki, Sowjanya, Reganti, Sunandana, Chandra, Samantha, Guild, Helen X, Chen, Howard Z, Streicher, Jedd D, Wolchok, Antoni, Ribas, John M, Kirkwood
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 41(2)
Combination programmed cell death protein 1/cytotoxic T-cell lymphocyte-4-blockade and dual BRAF/MEK inhibition have each shown significant clinical benefit in patients withIn a phase III trial, patients with treatment-naiveA total of 265 patients we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2ece5ce76d135a1efb5077c751df1e39
https://pubmed.ncbi.nlm.nih.gov/36166727
https://pubmed.ncbi.nlm.nih.gov/36166727
Autor:
Brian R. Gastman, Ahmad A. Tarhini, Robert M. Conry, Pauline Funchain, Karl D. Lewis, Antoni Ribas, Sapna Pradyuman Patel, Hongli Li, Kenneth F. Grossmann, Magdalena Kovacsovics-Bankowski, Teresa M. Petrella, Elizabeth I. Buchbinder, Nageatte Ibrahim, Ragini R. Kudchadkar, James Moon, Douglas B. Johnson, Thach-Giao Truong, Larissa A. Korde, Michael V. Knopp, Kari Kendra, Elad Sharon, Scot Ebbinghaus, Bartosz Chmielowski, Vernon K. Sondak, John M. Kirkwood, Zeynep Eroglu, Nikhil I. Khushalani, Justine V. Cohen, Megan Othus, Krishna S Gunturu, Sama Ahsan
Publikováno v:
Cancer discovery, vol 12, iss 3
Cancer Discov
Cancer Discov
We conducted a randomized phase III trial to evaluate whether adjuvant pembrolizumab for one year (647 patients) improved recurrence-free survival (RFS) or overall survival (OS) in comparison with high-dose IFNα-2b for one year or ipilimumab for up
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be95c3ea01eedee0bb4c9a85fc5d89b2
https://escholarship.org/uc/item/8x51z8rb
https://escholarship.org/uc/item/8x51z8rb
Publikováno v:
Current oncology reportsPapers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance. 24(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da4a0645a75561332490154bcbd4bf03
https://pubmed.ncbi.nlm.nih.gov/35192117
https://pubmed.ncbi.nlm.nih.gov/35192117
Autor:
Sachdev P. Thomas, Amit Arora, Hui X. Huang, Chen Jiang, Elaine Chung, Jennifer Marie Suga, Tilak Kumar Sundaresan, Thach-Giao Truong, Minggui Pan, Andrea Harzstark
Publikováno v:
Journal of Clinical Oncology. 41:261-261
261 Background: Androgen deprivation therapy (ADT) plus either Abiraterone, Docetaxel or Enzalutamide (ADE) improves overall survival (OS) of men with metastatic M1 castrate-sensitive prostate cancer (mCSPC), compared to ADT alone and is currently st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::554c9745c3c39097762bc111fd3e3bb9
https://doi.org/10.1200/jco.2023.41.6_suppl.261
https://doi.org/10.1200/jco.2023.41.6_suppl.261
Autor:
Jennifer Marie Suga, Ninah Achacoso, Pam Tse, Amit Arora, Wenwei Hu, Stacey E. Alexeeff, Elaine Chung, Tilak Kumar Sundaresan, Chen Jiang, Thach-Giao Truong, Laurel A. Habel, Sachdev P. Thomas, Aleyda V Solorzano, Minggui Pan
Publikováno v:
J Clin Oncol
PURPOSE To examine the association of gain-of-function (GOF) and non–gain-of-function (non-GOF) TP53 mutations with prognosis of metastatic right-sided (RCC) versus left-sided colorectal cancer (LCC). METHODS This cohort study included patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b715307a9b7370c4901417e2740060a3
https://europepmc.org/articles/PMC8718185/
https://europepmc.org/articles/PMC8718185/